Taken together, the data indicate that PPB exhibits a distinctive molecular signature when compared to CPAM, which includes the ligands FGF9 and SHH as well as the lung epithelial transcriptional regulators ETV4, ETV5, ELF5, IRX2 and IRX5. This evidence concerns the gene IRX5 and pleuropulmonary blastoma.